Ninkovic S, Harrison SJ, Lee J-J, Murphy N, Lee JH, Estell J, Chen VM, Horvath N, Kim K, Eek R, Augustson B, Bang S-M, Huang S-Y, Rajagopal R, Szabo F, Engeler D, Butcher BE, Mollee P, Durie B, Chng WJ, Quach H. Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study. haematol [Internet]. 2024Jul.1 [cited 2024Jul.3];109(7):2229-38. Available from: https://haematologica.org/article/view/haematol.2023.284238